Comparison of Ergon Instruments-Assisted Soft Tissue Mobilization With Compressive Myofascial Release

NCT ID: NCT05258188

Last Updated: 2022-06-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to investigate the effects of Virtual Reality and Motor Imagery along with Routine Physical Therapy in motor function and balance in patients with Parkinson disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized control trial is the single blinded, single centered study. Standard Protocol Items: Recommendations for Interventional Trials guidelines are used as study protocol. Sixty three patients of Parkinson Disease (Modified Hoehn and Yahr stages I-III) will randomly allocate into three groups.

Group A will be given a 60 min session of Virtual Reality along with Routine Physical Therapy.

Group B will be given a 60 min session of Motor Imagery along with Routine Physical Therapy.

Group C will be given a 40 min session of Routine Physical Therapy and after a short period of rest,20 min for walking and cycling.

These treatment sessions will be given to each group at every alternative day (3 days per week) for 12 weeks.

Outcome measures are

1. Berg Balance Scale
2. Activities Specific Balance Confidence Scale
3. The Unified Parkinson Disease Rating Scale (part III) The Assessments will be recorded at baseline, at 6th and 12th weeks of therapy, and after one month of discontinuation of therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Plantar Fasciitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Our study will be single-blinded, outcome assessor-blinded. The assessor will be blinded to avoid being biased during the outcome assessment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Instrument-assisted Soft Tissue Mobilization

1. Warm-up will be performed for 10 to 15 minutes by light jogging, elliptical machine, stationary cycle or an upper body ergometer
2. Instrument-assisted Soft Tissue Mobilization , will be applied at 30 to 60 degrees angle for 40 to 120 seconds
3. Stretching, for 30 seconds (3 rep)
4. Strengthening exercises, high repetitions with low intensity exercise
5. Cryotherapy for 10 to 20 min

Group Type EXPERIMENTAL

Instrument-assisted Soft Tissue Mobilization

Intervention Type OTHER

Instrument-assisted soft tissue mobilization is used for a mechanical benefit for the therapist providing deeper approach and braces remodeling of connective tissues through dissolution of extravagant fibrosis, while provoking repair and reconstructing forwarded by the recruitment of fibroblast.

Compressive Myofascial Release Technique

Compressive myofascial release technique will be applied 5 minutes, after a warmup of 10 to 15 minutes.

Group Type EXPERIMENTAL

Compressive Myofascial Release Technique

Intervention Type OTHER

Compressive Myofascial Release Technique is a technique of soft tissue stretching that uses compression and sustained myofascial stretches to create a releasing force in the targeted area

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Instrument-assisted Soft Tissue Mobilization

Instrument-assisted soft tissue mobilization is used for a mechanical benefit for the therapist providing deeper approach and braces remodeling of connective tissues through dissolution of extravagant fibrosis, while provoking repair and reconstructing forwarded by the recruitment of fibroblast.

Intervention Type OTHER

Compressive Myofascial Release Technique

Compressive Myofascial Release Technique is a technique of soft tissue stretching that uses compression and sustained myofascial stretches to create a releasing force in the targeted area

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Inability to achieve 20 degrees of active dorsiflexion,
* Heel pain,
* Mid foot pain,
* Heal swelling,
* Mid foot swelling,
* Achilles' tendon tightness diagnosed on the base of Windlass test

Exclusion Criteria

* Recent foot injury,
* Fracture,
* Infections,
* Surgical procedures,
* Tendon injury,
* Hypermobility,
* Neuromuscular disorders,
* Impaired sensation,
* Open sores,
* Skin disease,
* Active deep vein thrombosis or thrombophlebitis,
* Bruises,
* Varicose veins,
* Burn scars
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Kashif

Role: STUDY_CHAIR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ripah International University

Faisalabad, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC-FSD-00266

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.